Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells
2021 · Stem Cell Reviews and Reports · 75 citations
https://doi.org/10.1007/s12015-020-10092-9
H
Hongyu Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
143
Papers
2.4K
Citations
27
h-index
51
i10-index
Hongyu Zhang is an academic researcher from Long Island University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Immune Cell Function and Interaction & Histone Deacetylase Inhibitors Research. The author has an h-index of 27, co-authored 122 publications.
ORCID: 0000-0003-0858-8681Papers by this author
worksEstradiol improves cardiovascular function through up-regulation of SOD2 on vascular wall
2014 · Redox Biology · 71 citations
https://doi.org/10.1016/j.redox.2014.11.001
Basiliximab for steroid‐refractory acute graft‐versus‐host disease: A real‐world analysis
2022 · American Journal of Hematology · 57 citations
https://doi.org/10.1002/ajh.26475
SIRT1‐mediated ERβ suppression in the endothelium contributes to vascular aging
2016 · Aging Cell · 45 citations
https://doi.org/10.1111/acel.12515
HKDC1 C-terminal based peptides inhibit extranodal natural killer/T-cell lymphoma by modulation of mitochondrial function and EBV suppression
2020 · Leukemia · 40 citations
https://doi.org/10.1038/s41375-020-0801-5
Plasma microRNA-586 is a new biomarker for acute graft-versus-host disease
2015 · Annals of Hematology · 28 citations
https://doi.org/10.1007/s00277-015-2414-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat